Abstract:This study aims to investigate the potential use of polymer inclusion in the phospholipid-based solid dispersion approach for augmenting the biopharmaceutical performance of Aprepitant (APT). Initially, different polymers were screened using the microarray plate method to assess their ability to inhibit drug precipitation in the supersaturated solution and HPMCAS outperformed the others. Later, the binary (BD) and ternary (TD) phospholipid dispersions were prepared using the co-solvent evaporation method. Solid-state characterization was performed using SEM and PXRD to examine the physical properties, while molecular interactions were probed through FTIR and NMR analysis. In vitro dissolution studies were performed in both fasted and fed state biorelevant media. The results demonstrated a substantial increase in drug release from BD and TD, approximately 4.8 and 9.9 times higher compared to crystalline APT in FaSSIF. Notably, TD also showed a lowered dissolution difference between fed and fasted states in comparison to crystalline APT, indicating a reduction in the positive food effect of APT. Moreover, we assessed the impact of polymer inclusion on permeation under in vitro biomimetic conditions. In comparison with the crystalline APT suspension, both BD and TD demonstrated approximately 3.3 times and 14 times higher steady-state flux (J ss values), respectively. This can be ascribed to the supersaturation and presence of drug-rich submicron particles (nanodroplets) along with the multiple aggregates of drug with phospholipids and polymer in the donor compartment, consequently resulting in a more substantial driving force for passive diffusion. Lastly, in vivo pharmacokinetic evaluation demonstrated the enhanced absorption of both TD and BD over the free drug suspension in the fasted state. This enhancement was evident through a 2.1-fold and 1.3-fold increase in C max and a 2.3-fold and 1.4-fold increase in AUC 0-t , respectively. Overall, these findings emphasize the potential of polymer-based phospholipid dispersion in enhancing the overall biopharmaceutical performance of APT.

Preparation and Characterization of Aprepitant Solid Dispersion with HPMCAS-LF

Preparation and Characterization of Solid Dispersions of Dipyridamole with a Carrier “copolyvidonum Plasdone®S-630”

Supersaturable diacyl phospholipid dispersion for improving oral bioavailability of brick dust molecule: A case study of Aprepitant

Development and Optimization of Aprepitant/hs15/tw80 Composite System: Based on Micellization Thermodynamics

A Comparison on Preparation Methods for Solid Dispersion of Puerarin

Dissolution Improvement of Cisapride by Solid Dispersion with HPMC

Fabrication of an Aprepitant Nanosuspension Using Hydroxypropyl Chitosan to Increase the Bioavailability.

Preliminary Development of Solid Dispersion for an Insoluble Compound ZL006 by Miniaturized Hot Melt Extrusion

Studies on Preparation of Trimetazidine Solid Dispersion and Its Sustained Release Performance

Oral Bioavailability Enhancement of Poorly Soluble Drug by Amorphous Solid Dispersion Using Sucrose Acetate Isobutyrate

Lacidipine Amorphous Solid Dispersion Based on Hot Melt Extrusion: Good Miscibility, Enhanced Dissolution, and Favorable Stability

Preparation, Characterization and in Vitro Evaluation of Solid Dispersions Containing Docetaxel

The Impact of Solid Dispersion on Formulation, Using Confocal Micro Raman Spectroscopy as Tool to Probe Distribution of Components

Preparation of Iguratimod Solid Dispersion via Hot-melt Extrusion and Investigation of Factors Affecting Dissolution Profile

15-Hydroxystearate Micelles for the Delivery of Aprepitant: Preparation, Characterization, Pharmacokinetics and Tissue Distribution in Mice.

Improved dissolution and anti-inflammatory effect of ibuprofen by solid dispersion

A Combined Utilization of Plasdone-S630 and HPMCAS-HF in Ziprasidone Hydrochloride Solid Dispersion by Hot-Melt Extrusion to Enhance the Oral Bioavailability and No Food Effect

Development of Apremilast Solid Dispersion Using TPGS and PVPVA with Enhanced Solubility and Bioavailability

Effect of Carrier Lipophilicity and Preparation Method on the Properties of Andrographolide–Solid Dispersion

Formulation optimization of aprepitant microemulsion-loaded silicated corn fiber gum particles for enhanced bioavailability

Study on the Preparation and Dissolution of Flupirtine Maleate Solid Dispersions